These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
417 related items for PubMed ID: 17969490
1. Loss of hepatitis B immunity in hemodialysis patients acquired either naturally or after vaccination. Tsouchnikas I, Dounousi E, Xanthopoulou K, Papakonstantinou S, Thomoglou V, Tsakiris D. Clin Nephrol; 2007 Oct; 68(4):228-34. PubMed ID: 17969490 [Abstract] [Full Text] [Related]
2. Evolution of naturally acquired hepatitis B immunity in the long-term hemodialysis population. Charest AF, Grand'Maison A, McDougall J, Goldstein MB. Am J Kidney Dis; 2003 Dec; 42(6):1193-9. PubMed ID: 14655191 [Abstract] [Full Text] [Related]
3. [Long-term evaluation of immune response to hepatitis B vaccine in 136 patients undergoing hemodialysis]. Pin M, Compte MT, Angelet P, Gállego C, Gutiérrez C, Martinez Vea A. Nefrologia; 2009 Dec; 29(5):415-20. PubMed ID: 19820753 [Abstract] [Full Text] [Related]
4. Significance and anamnestic response in isolated hepatitis B core antibody-positive individuals 18 years after neonatal hepatitis B virus vaccination in Taiwan. Su FH, Bai CH, Chu FY, Lin YS, Su CT, Yeh CC. Vaccine; 2012 Jun 08; 30(27):4034-9. PubMed ID: 22531558 [Abstract] [Full Text] [Related]
5. Comparison of two immunization schedules with recombinant hepatitis B vaccine and natural immunity acquired by hepatitis B infection in dialysis patients. el-Reshaid K, al-Mufti S, Johny KV, Sugathan TN. Vaccine; 1994 Jun 08; 12(3):223-34. PubMed ID: 8165854 [Abstract] [Full Text] [Related]
6. Comparison of hepatitis B surface antibody decay rates after vaccination between hemodialysis and peritoneal dialysis patients. Lin SY, Liu JH, Lin CC, Wang SM, Tsai CA, Chou CY, Kuo HL, Wang IK, Liu YL, Lin HH, Huang CC. Vaccine; 2011 May 12; 29(21):3738-41. PubMed ID: 21458609 [Abstract] [Full Text] [Related]
7. [Are teenagers immunized in infancy still protected against hepatitis B?]. Pokorska-Lis M, Marczyńska M. Przegl Lek; 2010 May 12; 67(1):13-7. PubMed ID: 20509565 [Abstract] [Full Text] [Related]
8. Hepatitis B immunity and response to booster vaccination in children with inflammatory bowel disease treated with infliximab. Moses J, Alkhouri N, Shannon A, Raig K, Lopez R, Danziger-Isakov L, Feldstein AE, Zein NN, Wyllie R, Carter-Kent C. Am J Gastroenterol; 2012 Jan 12; 107(1):133-8. PubMed ID: 21876562 [Abstract] [Full Text] [Related]
9. Titers of antibodies to the surface antigen of hepatitis B virus after vaccination in relation to immunity-related gene variants. A prospective study among hemodialysis patients. Jodłowska-Siewert E, Jagodziński PP, Grzegorzewska AE. Pol Arch Intern Med; 2017 Aug 09; 127(7-8):481-489. PubMed ID: 28817541 [Abstract] [Full Text] [Related]
15. The evaluation of immune responses that occur after HBV infection and HBV vaccination in hemodialysis patients. Kara IH, Yilmaz ME, Suner A, Kadiroglu AK, Isikoglu B. Vaccine; 2004 Sep 28; 22(29-30):3963-7. PubMed ID: 15364445 [Abstract] [Full Text] [Related]
17. Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study. Zanetti AR, Mariano A, Romanò L, D'Amelio R, Chironna M, Coppola RC, Cuccia M, Mangione R, Marrone F, Negrone FS, Parlato A, Zamparo E, Zotti C, Stroffolini T, Mele A, Study Group. Lancet; 2004 Sep 28; 366(9494):1379-84. PubMed ID: 16226616 [Abstract] [Full Text] [Related]